Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02403505
Title Discovery Stage Clinical Study About Oncology Drugs and Single Nucleotide Polymorphisms
Acronym 9vHPV-BCG
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Dr. Han Xu, President/CEO / PD / PI / Monitor / IRB Chair
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.